Recombinant DNA: 250 Years of US Innovation

Recombinant DNA (rDNA) technology has fundamentally reshaped medicine by enabling the mass production of targeted biopharmaceuticals. Its history serves as a blueprint for governing rapid technological innovation through collective scientific self-regulation.

Key Takeaways

• 1.Recombinant DNA (rDNA) technology transformed the biotechnology industry by enabling the mass production of humanized therapies.
• 2.The 1975 Asilomar Conference established a crucial model for self-regulation in scientific innovation, balancing safety with development.
• 3.Commercial success for early biotech companies like Genentech catalyzed massive capital inflows into the sector, totaling over $1 trillion in revenue for rDNA-related therapies.

Table of Contents

• Editorial
• Infographic
• The history lesson
• A modern view

Document Preview

Page 1 of 1

Subscribe for full accessStart Free Trial